...
nkgn-img

NKGen Biotech, Inc. Common Stock, Common Stock

NKGN

NMQ

$0.3722

-$0.04

(-9.59%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$12.85M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
698.70K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.52
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.2 L
$4 H
$0.3722

About NKGen Biotech, Inc. Common Stock, Common Stock

NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. Its lead products include SNK01, an autologous NK cell therapy candidate treatment for neurodegenerative diseases; and SNK02, an allogeneic NK cell therapy, which is in Phase 1 clinical trials for refractory solid tumors. The company has a license agreement with NKMAX. The company was formerly known as NKMAX America, Inc. NKGen Biotech, Inc. was founded in 2017 and is headquartered in Santa Ana, California. NKGen Biotech, Inc. operates as a subsidiary of NKMAX Co., Ltd. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameNKGNSectorS&P500
1-Week Return18.91%2.3%1.73%
1-Month Return6.34%-1.77%3.44%
3-Month Return-50.33%-6.07%7.02%
6-Month Return-75.19%2.45%13.38%
1-Year Return-87.08%12.17%32.25%
3-Year Return-96.16%10.46%29.27%
5-Year Return-96.16%46.4%90.61%

Financials

Dec '21Dec '22Dec '23
Total Revenue426.00K77.00K-[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":18.08,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue30.00K18.00K1.20M[{"date":"2021-12-31","value":2.49,"profit":true},{"date":"2022-12-31","value":1.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit396.00K59.00K(1.20M)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":14.9,"profit":true},{"date":"2023-12-31","value":-303.79,"profit":false}]
Gross Margin92.96%76.62%-[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":82.43,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses22.26M24.41M28.54M[{"date":"2021-12-31","value":77.98,"profit":true},{"date":"2022-12-31","value":85.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(21.86M)(24.35M)(29.75M)[{"date":"2021-12-31","value":-2186100000,"profit":false},{"date":"2022-12-31","value":-2434600000,"profit":false},{"date":"2023-12-31","value":-2974600000,"profit":false}]
Total Non-Operating Income/Expense(2.71M)(4.71M)(53.95M)[{"date":"2021-12-31","value":-271400000,"profit":false},{"date":"2022-12-31","value":-470700000,"profit":false},{"date":"2023-12-31","value":-5394600000,"profit":false}]
Pre-Tax Income(23.26M)(26.75M)(82.95M)[{"date":"2021-12-31","value":-2326000000,"profit":false},{"date":"2022-12-31","value":-2674700000,"profit":false},{"date":"2023-12-31","value":-8294700000,"profit":false}]
Income Taxes5.00K7.00K7.00K[{"date":"2021-12-31","value":71.43,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(23.27M)(26.75M)(82.95M)[{"date":"2021-12-31","value":-2326500000,"profit":false},{"date":"2022-12-31","value":-2675400000,"profit":false},{"date":"2023-12-31","value":-8295400000,"profit":false}]
Income From Continuous Operations(23.27M)(26.75M)(82.95M)[{"date":"2021-12-31","value":-2326500000,"profit":false},{"date":"2022-12-31","value":-2675400000,"profit":false},{"date":"2023-12-31","value":-8295400000,"profit":false}]
Income From Discontinued Operations---[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(23.27M)(26.75M)(82.95M)[{"date":"2021-12-31","value":-2326500000,"profit":false},{"date":"2022-12-31","value":-2675400000,"profit":false},{"date":"2023-12-31","value":-8295400000,"profit":false}]
EPS (Diluted)(0.05)0.21(4.10)[{"date":"2021-12-31","value":-23.81,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1953.67,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NKGN
Cash Ratio 0.00
Current Ratio 0.02
Quick Ratio 0.00

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NKGN
ROA (LTM) -106.85%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NKGN
Debt Ratio Lower is generally better. Negative is bad. 5.46
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -4.46

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NKGN
Trailing PE NM
Forward PE NM
P/S (TTM) 1215.21
P/B 0.00
Price/FCF NM
EV/R 964.78
EV/Ebitda NM

FAQs

What is NKGen Biotech, Inc. Common Stock share price today?

NKGen Biotech, Inc. Common Stock (NKGN) share price today is $0.3722

Can Indians buy NKGen Biotech, Inc. Common Stock shares?

Yes, Indians can buy shares of NKGen Biotech, Inc. Common Stock (NKGN) on Vested. To buy NKGen Biotech, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NKGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of NKGen Biotech, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of NKGen Biotech, Inc. Common Stock (NKGN) via the Vested app. You can start investing in NKGen Biotech, Inc. Common Stock (NKGN) with a minimum investment of $1.

How to invest in NKGen Biotech, Inc. Common Stock shares from India?

You can invest in shares of NKGen Biotech, Inc. Common Stock (NKGN) via Vested in three simple steps:

  • Click on Sign Up or Invest in NKGN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in NKGen Biotech, Inc. Common Stock shares
What is NKGen Biotech, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of NKGen Biotech, Inc. Common Stock (NKGN) is $4. The 52-week low price of NKGen Biotech, Inc. Common Stock (NKGN) is $0.2.

What is NKGen Biotech, Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of NKGen Biotech, Inc. Common Stock (NKGN) is

What is NKGen Biotech, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of NKGen Biotech, Inc. Common Stock (NKGN) is 0.00

What is NKGen Biotech, Inc. Common Stock dividend yield?

The dividend yield of NKGen Biotech, Inc. Common Stock (NKGN) is 0.00%

What is the Market Cap of NKGen Biotech, Inc. Common Stock?

The market capitalization of NKGen Biotech, Inc. Common Stock (NKGN) is $12.85M

What is NKGen Biotech, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of NKGen Biotech, Inc. Common Stock is NKGN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top